Report overview
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells (iPSCs). This report contains market size and forecasts of Induced Pluripotent Stem Cells (iPSCs) in global, including the following market information:
Global Induced Pluripotent Stem Cells (iPSCs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 104.4 million in 2022 and is projected to reach US$ 227.6 million by 2029, at a CAGR of 11.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
We surveyed the Induced Pluripotent Stem Cells (iPSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Induced Pluripotent Stem Cells (iPSCs) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, by Type, 2022 (%)
Human iPSCs
Mouse iPSCs
Global Induced Pluripotent Stem Cells (iPSCs) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, by Application, 2022 (%)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Global Induced Pluripotent Stem Cells (iPSCs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Induced Pluripotent Stem Cells (iPSCs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Induced Pluripotent Stem Cells (iPSCs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Induced Pluripotent Stem Cells (iPSCs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Induced Pluripotent Stem Cells (iPSCs), market overview.
Chapter 2: Global Induced Pluripotent Stem Cells (iPSCs) market size in revenue.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Induced Pluripotent Stem Cells (iPSCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
